Last $23.80 USD
Change Today +0.53 / 2.28%
Volume 8.4K
FMI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 10:04 AM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Todd R. Golub M.D.

Founding Advisor, Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 62 board members in 3 different organizations across 7 different industries.

See Board Relationships
----

Background*

Dr. Todd R. Golub, M.D. serves as Scientific Founder at H3 Biomedicine Inc. Dr. Golub is the Founding Director of the Cancer Program at the Broad Institute of Harvard and MIT, and also serves as the Institute’s Chief Scientific Officer. Dr. Golub is also the Charles A. Dana Investigator at the Dana-Farber Cancer Institute, Professor of Pediatrics at Harvard Medical School, and an investigator at the Howard Hughes Medical Institute. Dr. Golub is internationally known ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2201

Board Members Memberships*

Director

Education*

BA 1985
Carleton College
MD 1989
University Of Chicago - Pritzker School Of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FMI:US $23.80 USD +0.53

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$400.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$649.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.